Coordination-Stabilized Manganese(IV) Peptide Hydrogels Reveal Valence-Dependent Structure and Immunomodulation
Source abstract
Abstract
High-valence manganese is typically confined to solid oxide precursors in manganese-based biomaterials, leaving valence-dependent coordination-structure-function relationships largely unresolved. Here, we established a peptide-coordinated hydrogel platform that stabilized Mn(IV) in an aqueous/gel environment and enabled direct comparison between Mn(II)- and Mn(IV)-dominated supramolecular networks. By tuning FE tandem repeats, two representative systems, FE3-Mn(II) and FE4-Mn(IV), were constructed with distinct manganese valence distributions and coordination environments. These valence-defined hydrogels exhibited differentiated secondary-structure organization, nanofiber hierarchy, and viscoelastic relaxation behavior, indicating that manganese valence governed both network topology and dynamic reorganization. Functionally, FE3-Mn(II) more effectively enhanced innate immune priming, whereas FE4-Mn(IV) more strongly promoted redox stress and immunogenic cell death-associated signals. In a 4T1 tumor model, both hydrogels suppressed tumor growth and enhanced intratumoral immune infiltration, with FE4-Mn(IV) showing stronger overall antitumor efficacy and more spatially organized immune distributions. These results identified metal valence as a definable coordination variable in peptide hydrogels and revealed how valence-dependent network structure and dynamics relate to downstream immunomodulatory outputs, providing a basis for the design of manganese-based local immunomodulatory biomaterials.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Diatoms and Algae Research · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Biotechnology and Pharmaceutical Engineering
Nanjing Tech University
School of Pharmaceutical Sciences
Department of Orthopaedic Surgery, Institute of Digital Medicine, Nanjing First Hospital
Nanjing Medical University
Funding
National Key Research and Development Program of China · Natural Science Foundation of Jiangsu Province · National Natural Science Foundation of China · Postgraduate Research & Practice Innovation Program of Jiangsu Province
References (21)
Show source-provided references
1. 10.3390/ijerph12070751910.3390/ijerph120707519 ↗
2. 10.1016/j.immuni.2018.03.01710.1016/j.immuni.2018.03.017 ↗
3. 10.1038/s41423-021-00669-w10.1038/s41423-021-00669-w ↗
4. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
5. 10.1016/j.drup.2004.01.00410.1016/j.drup.2004.01.004 ↗
6. 10.1021/acsbiomaterials.1c0160510.1021/acsbiomaterials.1c01605 ↗
7. 10.1002/adma.20140514110.1002/adma.201405141 ↗
8. 10.1002/adma.20190582310.1002/adma.201905823 ↗
9. 10.1021/acsnano.2c0096910.1021/acsnano.2c00969 ↗
10. 10.1002/adma.20241436510.1002/adma.202414365 ↗
11. 10.1002/adma.20230358010.1002/adma.202303580 ↗
12. 10.1002/smll.20250875210.1002/smll.202508752 ↗
13. 10.1039/C5CS00234F10.1039/C5CS00234F ↗
14. 10.1021/acsami.9b1790710.1021/acsami.9b17907 ↗
15. 10.1016/j.jconrel.2022.12.03110.1016/j.jconrel.2022.12.031 ↗
16. 10.1016/j.cej.2025.17086410.1016/j.cej.2025.170864 ↗
17. 10.1002/adfm.20180735610.1002/adfm.201807356 ↗
18. 10.1021/acsami.1c2014610.1021/acsami.1c20146 ↗
19. 10.1002/anie.20161055110.1002/anie.201610551 ↗
20. 10.1016/S1386-1425(03)00279-810.1016/S1386-1425(03)00279-8 ↗
21. 10.1093/protein/5.3.19110.1093/protein/5.3.191 ↗